Home Blog Page 29

TIER IV unveils end-to-end autonomous driving adaptable to map information and sensor configurations

Multiple open-source AI models are available with Autoware

TOKYO, Nov. 11, 2026 /PRNewswire/ — TIER IV, the pioneering force behind Autoware, open-source software for autonomous driving, today announced the development and open-source release of multiple end-to-end (E2E) autonomous driving AI models that support different system requirements, including map information and sensor configurations. The models offer flexible options ranging from camera-only configurations to those incorporating LiDAR, radar and high-definition (HD) maps, enabling developers to select AI models suited to their performance requirements. Through Autoware, TIER IV provides a development environment for optimizing these models and integrating them into vehicle systems, helping automakers and technology partners develop and deploy their own autonomous driving stack.

Overview of the Autoware 2.0 Architecture

TIER IV is leading the development of Autoware 2.0, the next-generation architecture of Autoware. Autoware 2.0 is a scalable and adaptable architecture that flexibly combines AI models with conventional rule-based technologies. By supporting different AI models and sensor configurations, it enables autonomous driving systems to be built for a range of applications and system requirements. The E2E autonomous driving AI models announced today are concrete technological outcomes designed to leverage this architecture.

NVIDIA Alpamayo 2 Edge

As part of its collaboration with NVIDIA announced in March 2026 , TIER IV has been evaluating the performance of NVIDIA Alpamayo, a vision-language-action (VLA) foundation model, and integrating it with Autoware. The latest model, Alpamayo 2 Edge, is an E2E autonomous driving AI model that takes only camera images as input and uses reasoning to generate driving trajectories. With 2 billion parameters, compared with 34 billion in Alpamayo 2 Super, it is substantially smaller and offers promise for practical deployment in vehicles. TIER IV is currently optimizing the model and adapting it to real vehicles, while having completed its integration with Autoware.

AutoE2E

AutoE2E, whose development is led by the Autoware Foundation (AWF) and TIER IV, is an E2E autonomous driving AI model capable of running on computing platforms beyond NVIDIA hardware. It adopts a Fast–Slow architecture combining a Reactive Model for real-time driving decisions, a World Model for predicting future changes in the surrounding environment, and a Reasoning Model that supports driving decisions. It can accommodate configurations ranging from cameras alone to those incorporating LiDAR and radar sensor data. With 79.9 million parameters, it is lighter than Alpamayo 2 Edge. The Reactive Model has been released, while development of the World Model and Reasoning Model continues, alongside consideration of commercialization for robotaxi applications. Integration of the Reactive Model with Autoware has been achieved.

METEOR

Developed independently by TIER IV, METEOR is a lightweight, multitask E2E autonomous driving AI model primarily intended for privately owned passenger vehicles. Built on a convolutional neural network (CNN) architecture, it uses a bird’s-eye-view (BEV) representation to perform everything from perception of the surrounding environment to driving trajectory generation within a single neural network, without relying on high-definition maps. It supports configurations using images from one to eight cameras and can also incorporate LiDAR and radar sensor data. With 16 million parameters, it is even lighter than AutoE2E and supports operation across different semiconductor platforms, including NVIDIA and Renesas. TIER IV also uses CoMET, the automated labeling platform within Co-MLOps, together with agentic AI to automate data labeling and model training, evaluation, and improvement, eliminating the need for manual coding and labeling. Automakers and component suppliers can optimize the open-source model to meet their own vehicle specifications and performance requirements.

OnePlanner

OnePlanner is an E2E autonomous driving AI model that integrates perception of the surrounding environment with motion planning. It currently uses BEVFusion, which generates a BEV representation from LiDAR point-cloud data, with a planned transition to PTv3. Its flexible architecture allows the perception model to be replaced while directly using features extracted during perception for motion planning. Conventional autonomous driving systems convert perception results into information such as object positions and velocities before passing them to the planner. OnePlanner reduces these intermediate conversions, enabling richer use of information about the surrounding environment. It also incorporates HD maps, route information, traffic-signal states, and vehicle motion states to generate driving trajectories for the next six seconds. Integration with Autoware has been achieved.

LatentDrive

LatentDrive is an E2E autonomous driving AI model that uses a world model to integrate predictions of the surrounding environment with motion planning. Using V-JEPA, a self-supervised learning approach, it represents features of the surrounding environment extracted from camera video in a latent space and uses these features to generate vehicle trajectories. Its distinguishing feature is that it directly leverages information from video for motion planning without intermediate processes such as object detection and tracking. It does not require HD maps and generates trajectories for the next four seconds using camera video, route information, and vehicle motion states. It supports configurations with either one or three cameras, and work is underway on integration with Autoware and validation in an in-vehicle environment.

“Advances in E2E autonomous driving are fundamentally changing how autonomous driving systems are developed.” said Shinpei Kato, founder and CEO of TIER IV. “For automakers and component suppliers to incorporate AI technology into their own products, however, it is essential that they be able to internalize technologies according to their applications and performance requirements, without depending on a particular AI model or semiconductor platform. By releasing multiple AI models developed under the leadership of TIER IV and the Autoware Foundation, alongside the results of our collaboration with NVIDIA, we have significantly expanded those choices. We will continue to advance the open-source ecosystem centered on Autoware and work with partners around the world to democratize autonomous driving.”

“Advancing autonomous driving requires AI that can reason through complex situations and run efficiently in the car.” said Ali Kani, vice president of automotive at NVIDIA. “TIER IV’s integration of NVIDIA Alpamayo 2 Edge with Autoware gives developers an open foundation to bring that intelligence from research into their own vehicles.”

“The advancement of autonomous driving technology depends on an ecosystem in which diverse AI models can be developed and evaluated openly, then applied according to their respective use cases.” said Muhammad Zain Khawaja, President of the Autoware Foundation. “The AI models released today are an important demonstration of how Autoware is evolving into a flexible development platform that is not tied to any particular technology or hardware. We welcome TIER IV’s continued technology development and its collaboration with partners including NVIDIA. The Autoware Foundation will continue working with the global open-source community to make advanced autonomous driving technology accessible to everyone.”

Next Steps

TIER IV will continue improving the performance of the AI models released today and optimizing them for in-vehicle environments, while promoting the development and commercialization of E2E autonomous driving technology by automakers and partners through Autoware. TIER IV will also strengthen collaboration with the global open-source community and work to expand the adoption of autonomous driving systems across diverse vehicle types and applications.

About TIER IV

TIER IV stands at the forefront of deep tech innovation, pioneering Autoware, open-source software for autonomous driving. With a comprehensive suite of platforms and services built around Autoware, TIER IV provides everything from software development and vehicle procurement to operational support. Through the Autoware ecosystem, TIER IV works with partners worldwide to shape the future of intelligent vehicles with open-source software, aiming to create mobility that is safer, more sustainable, and accessible to all.

The word marks and logos of TIER IV are trademarks or registered trademarks of TIER IV, Inc. in Japan and other countries. All other company names, product names, service names, and logos referenced herein are trademarks or registered trademarks of their respective owners.

Autoware is a registered trademark of the Autoware Foundation.

Media contact
pr@tier4.jp 

IASO Bio Announces NMPA IND Approval for IASO208, Advancing Its In Vivo CAR-T Platform into Synchronized U.S.-China Clinical Development

First lentiviral-vector-based in vivo CAR-T product from China to receive a U.S. FDA IND clearance; a Phase Ib study in R/R B-NHL will be initiated directly in the United States

SHANGHAI, NANJING, China, and PLEASANTON, Calif., Nov. 10, 2026 /PRNewswire/ — IASO Biotechnology (“IASO Bio”), a commercial-stage biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for hematologic malignancies and autoimmune diseases, today announced that its Investigational New Drug (IND) application for IASO208, a CD20-targeting in vivo CAR-T therapy developed on the company’s proprietary InTelliCAR™ platform, has been approved by the National Medical Products Administration (NMPA) of China. This follows the implicit clearance of the IASO208 IND by the U.S. Food and Drug Administration (FDA) in September 2026. As the first lentiviral-vector-based in vivo CAR-T product from China to receive an FDA IND clearance, IASO208 will build on investigator-initiated trial (IIT) data generated in China to initiate a Phase Ib clinical study directly in the United States, targeting adult patients with relapsed/refractory B-cell non-Hodgkin lymphoma (R/R B-NHL).

The approval of the China IND marks the formal entry of IASO’s InTelliCAR™ platform into a phase of synchronized U.S.–China clinical development, and further validates the feasibility of leveraging China’s early clinical data to support global registrational development. IASO208 is the company’s first product to obtain IND approval through China’s 30-day expedited review pathway. This not only reflects regulatory recognition of the scientific merit of IASO208, but also demonstrates that IASO has established mature, end-to-end capabilities across the full development value chain for in vivo CAR-T products—spanning chemistry, manufacturing and controls (CMC), nonclinical studies, clinical trial design, and communication with regulatory authorities.

IASO208 is currently being evaluated in an investigator-initiated, single-arm, open-label, dose-exploration study designed to assess its safety, tolerability and preliminary efficacy in patients with relapsed/refractory B-cell malignancies. In this study, patients are not required to undergo conventional apheresis or lymphodepleting conditioning and receive a single intravenous infusion of IASO208. To date, 11 patients have been dosed. Early data have demonstrated favorable tolerability and promising anti-tumor activity, laying a solid foundation for larger, more systematic clinical studies to be conducted in both China and the United States. The early results of this study have been selected for an Oral Presentation at the 2026 American Society of Hematology (ASH) Annual Meeting (Abstract :#705).

Ms. Jinhua Zhang, Founder, Chairperson and Chief Executive Officer of IASO Bio,stated:“The approval of the China IND for IASO208 is another milestone for IASO’s proprietary in vivo CAR-T platform, InTelliCAR™, following our receipt of FDA IND clearance. It marks a decisive step for this product—the first lentiviral-vector-based in vivo CAR-T from China to receive an FDA IND clearance—from ‘U.S. IND approval’ toward ‘synchronized U.S.–China clinical development.’ Leveraging the InTelliCAR™ platform, IASO has assembled a portfolio of in vivo CAR-T product candidates across hematologic malignancies, autoimmune diseases and solid tumors, with several candidates now in the IND-enabling stage. The launch of synchronized U.S.–China clinical development for IASO208 lays a critical foundation for the global expansion of the InTelliCAR™ platform. Looking ahead, IASO will accelerate the global clinical development of IASO208 so that this China-originated, innovative in vivo CAR-T product can reach and benefit an even broader patient population worldwide at an earlier date.”

About IASO Bio

Founded in 2017, IASO Bio is one of the few commercial-stage biopharmaceutical companies in the Advanced Therapy Medicinal Product (ATMP) sector bringing China‘s breakthrough innovations to the global market. We specialize in developing cell therapies and biologics for hematological malignancies and autoimmune diseases. Our industry-leading, fully integrated platforms leverage cutting-edge technologies that span the entire product lifecycle—from discovery and development to manufacturing and commercialization.

We have established a robust and synergistic pipeline, reflecting our commitment to making transformative cell therapies broadly accessible to patients worldwide. Our current portfolio includes ten products and product candidates, anchored by our core product, Equecabtagene Autoleucel (eque-cel). The CAR-T therapy Eque-cel has been approved in China for the treatment of relapsed or refractory multiple myeloma (r/r MM) in patients who have progressed after at least three prior lines of therapy. It is also being developed for use in earlier lines of r/r MM treatment and for autoimmune diseases, including myasthenia gravis (MG), multiple sclerosis (MS), and systemic lupus erythematosus (SLE)/lupus nephritis (LN). Beyond eque-cel, we are developing nine additional therapeutic candidates—including three autologous chimeric antigen receptor T-cell (CAR-T) therapies, five in vivo CAR-T cell therapies, and one antibody product candidate.

We collaborate with leading biotechnology and biopharmaceutical companies such as Innovent, Sana, Cabaletta, and Umoja, as well as top-tier academic institutions and hospitals, to strengthen our product development capabilities.

Hire A Maid Makes Domestic Helper Recruitment More Convenient for Singapore Families Through Digital-First Approach

From online shortlisting and video interviews to digital documentation and doorstep deployment, the Singapore agency is reducing the need for repeated agency visits while keeping personalised guidance at the heart of recruitment.


SINGAPORE – Media OutReach Newswire – 11 November 2026 – From banking to healthcare consultations, Singaporeans are increasingly accustomed to managing everyday services online. Yet for families looking to hire a full-time domestic helper, the process can still involve multiple agency visits, coordinating interviews and navigating paperwork. Singapore-based employment agency Hire A Maid is looking to simplify this experience by bringing more of the recruitment journey online, without losing the personal touch that comes with choosing someone to become part of a household’s daily life.

Hire A Maid's digital-first recruitment approach enables Singapore families to interview and assess prospective domestic helpers remotely through video calls, reducing the need for repeated agency visits while maintaining a personalised hiring experience.
Hire A Maid’s digital-first recruitment approach enables Singapore families to interview and assess prospective domestic helpers remotely through video calls, reducing the need for repeated agency visits while maintaining a personalised hiring experience.

Founded by Francis Wang, Hire A Maid combines online helper shortlisting, video interviews, digital documentation and doorstep deployment arrangements with personalised recruitment assistance. The approach allows employers to manage much of the hiring process remotely, reducing the need for repeated visits to a physical agency while maintaining guidance throughout the selection and hiring stages.

For working parents, dual-income households and families caring for young children or elderly relatives, finding time to visit an employment agency can be challenging. Beyond arranging interviews and reviewing candidates, employers must also consider whether a potential helper’s experience, strengths and expectations align with the specific needs of their household.

Through Hire A Maid’s online platform, families can browse profiles of fresh and experienced domestic helpers from Myanmar and Indonesia, shortlist suitable candidates and arrange video interviews before making a hiring decision. The agency also assists with the required documentation through digital processes and provides doorstep deployment arrangements, making the overall experience more convenient for busy households.

However, Hire A Maid believes that making recruitment more convenient should not come at the expense of finding a suitable match. Unlike a typical online transaction, hiring a domestic helper involves bringing someone into the household to support everyday family life, making mutual understanding and realistic expectations especially important.

“There are no perfect helpers or employers, only the right fit,” said Francis Wang, founder of Hire A Maid. “Our job is to help families make informed decisions while making the whole process less troublesome.”

According to Francis, a successful placement goes beyond a helper’s qualifications or previous experience. Every household has its own routines, responsibilities and expectations, whether the priority is childcare, elderly support or general household management. Likewise, domestic helpers bring different strengths, experience levels and personal backgrounds that need to be considered during the selection process.

Rather than focusing solely on how quickly a helper can be deployed, Hire A Maid places importance on understanding an employer’s requirements and helping families assess candidate suitability. This includes providing guidance during the shortlisting and interview stages, so employers can make more informed decisions and establish clearer expectations from the outset.

“Technology should take away the unnecessary running around, not the human element of recruitment,” Francis added. “Employers still need proper guidance, and helpers deserve clear expectations about the households they’ll be joining.”

By combining digital convenience with personalised assistance, Hire A Maid hopes to make domestic helper recruitment more accessible and less time-consuming for Singapore households. Its approach reflects a straightforward principle: families should spend less time managing the recruitment process and more time making the right hiring decision.

For more information about Hire A Maid’s recruitment services, visit www.hireamaid.sg.

The issuer is solely responsible for the content of this announcement.

About Hire A Maid

Hire A Maid is a Singapore domestic helper employment agency founded by Francis Wang. The company specialises in recruiting fresh and experienced full-time live-in domestic helpers from Myanmar and Indonesia. Its services combine online helper shortlisting, video interviews, digital documentation, doorstep deployment arrangements and personalised recruitment guidance for Singapore households.

Beyond Medical Group and Tamarind Health Advance Regional Expansion Through Strategic Partnership in Cambodia

Alliance with SingMed International Medical Centre strengthens Singapore–Cambodia healthcare cooperation and establishes a platform for cross-border specialist and oncology services.

PHNOM PENH, Cambodia, Nov. 11, 2026 /PRNewswire/ — 10 November 2026, Beyond Medical Group (BMG) and Tamarind Health have formalised a strategic partnership with SingMed International Medical Centre, marking a significant step in expanding their regional healthcare collaboration and strengthening Singapore–Cambodia healthcare connectivity.

Leaders from Beyond Medical Group, SingMed International, and Tamarind Health signed the partnership to bring together multidisciplinary specialist expertise from Singapore to Cambodia
Leaders from Beyond Medical Group, SingMed International, and Tamarind Health signed the partnership to bring together multidisciplinary specialist expertise from Singapore to Cambodia

Signed in conjunction with the grand opening of SingMed’s expanded medical centre in Phnom Penh, the agreement builds on BMG’s established relationship with SingMed since 2024 and reflects a shared vision to develop a more integrated healthcare ecosystem connecting Cambodia with Singapore’s specialist medical expertise.

As regional healthcare needs evolve, particularly in specialised and complex medical care, the partnership provides a strategic platform to strengthen clinical collaboration, expand cross-border healthcare services and explore longer-term opportunities in Cambodia’s healthcare sector.

Bridging Healthcare Expertise Across Borders

Combining BMG’s multidisciplinary specialist network, Tamarind Health’s oncology capabilities and SingMed’s local healthcare infrastructure, the alliance seeks to establish coordinated pathways for specialist consultation, multidisciplinary care and treatment across both countries.

Leaders and Doctors from Beyond Medical Group, SingMed International and Tamarind Health posed for a group picture together ahead the official opening ceremony of SingMed International Medical Centre in Phnom Penh
Leaders and Doctors from Beyond Medical Group, SingMed International and Tamarind Health posed for a group picture together ahead the official opening ceremony of SingMed International Medical Centre in Phnom Penh

Elayne Soh, CEO of Beyond Medical Group, said:

“Healthcare collaboration must go beyond cross-border patient referrals. Through this partnership, we aim to build a more connected healthcare model that brings multidisciplinary specialist and oncology expertise closer to patients in Cambodia.

Building on our partnership with SingMed since 2024, this collaboration with Tamarind Health marks another step towards strengthening regional healthcare connectivity and developing meaningful, long-term healthcare partnerships across Southeast Asia.”

Mr Eng Seng Lim, CEO of Tamarind Health, said:

“Cancer care is rarely managed by a single specialist. It often requires collaboration across oncology, surgery, diagnostics and other medical disciplines.

This partnership creates an opportunity to combine Tamarind Health’s oncology expertise with Beyond Medical Group’s wider specialist network and SingMed’s local presence in Cambodia.

By working together, we hope to strengthen cancer awareness, improve access to specialist advice and develop more coordinated care pathways for patients and their families.”

Okhna Pin Netra, Founder & Chairwoman of SingMed International Medical Centre, said:

“The opening of our expanded medical centre marks an important milestone for SingMed, but equally important is the network of healthcare expertise we are building around it.

Our partnership with Beyond Medical Group and Tamarind Health strengthens our ability to connect patients in Cambodia with a broader range of specialist and oncology expertise.

We look forward to developing practical programmes that bring international medical knowledge, specialist engagement and coordinated care closer to patients in Cambodia.”

Building a Regional Healthcare Platform

Looking ahead to 2027, the three organisations are exploring joint initiatives including specialist outreach programmes, patient education and oncology awareness activities, multidisciplinary case discussions and coordinated patient referrals.

The partnership underscores a shared commitment to strengthening healthcare cooperation between Cambodia and Singapore, advancing regional healthcare connectivity and paving the way for long-term growth and development across Southeast Asia.

About Beyond Medical Group

Beyond Medical Group is a Singapore-based specialist healthcare group bringing together doctors across multiple medical and surgical disciplines, supported by an integrated headquarters platform spanning patient engagement, communications, corporate partnerships and regional referrals.

Through its regional partnerships and representative networks, BMG works to connect overseas communities with appropriate specialist expertise in Singapore while supporting greater healthcare collaboration across Southeast Asia.

About Tamarind Health

Tamarind Health is an integrated oncology-focused healthcare group bringing together established cancer care practices and specialists across Asia. Headquartered in Singapore, its doctor-led network spans the cancer care journey, from diagnostics and treatment to survivorship and well-being.

With a purpose to set new standards in healthcare for better patient outcomes, Tamarind Health is building a connected platform for oncology and related services across six markets: Singapore, Hong Kong SAR, Malaysia, the Philippines, Vietnam and Mainland China. Its network includes OncoCare, TalkMed, Luma Women’s Imaging Centre, Solis Breast Care & Surgery Centre, Hong Kong Women’s Imaging Centre, Tamarind Specialists Centre, Can-Care and Novena Heart Centre.

About SingMed International Medical Centre

SingMed International Medical Centre is a healthcare provider based in Phnom Penh, Cambodia, providing outpatient, inpatient and multidisciplinary medical services.

Its expanded medical centre serves as a local healthcare platform supporting patient care, specialist engagement and collaboration with regional healthcare groups and medical professionals.

Chula Ranks No. 1 in Thailand for 11 Consecutive Years, Among Asia’s Top 3% of Universities

BANGKOK, Nov. 11, 2026 /PRNewswire/ — Chulalongkorn University has maintained its position as the No. 1 university in Thailand for the 11th consecutive year, with an overall score placing it among the top 3% of universities in Asia, according to the QS Asia University Rankings 2027, announced on November 3, 2026. A total of 1,722 universities across Asia were included in this year’s rankings. 

Chula Ranks No. 1 in Thailand for 11 Consecutive Years, Among Asia’s Top 3% of Universities
Chula Ranks No. 1 in Thailand for 11 Consecutive Years, Among Asia’s Top 3% of Universities

In addition, Chulalongkorn University achieved outstanding scores in two key areas: Academic Reputation, scoring 99.9 out of 100, and International Research Network, scoring 99.3 out of 100. These results reflect the university’s strong international recognition and standing in the global academic community. 

The QS Asia University Rankings 2027 evaluates universities based on 11 indicators, each carrying a different weighting: 

  • Academic Reputation – 30% 
  • Employer Reputation – 20% 
  • Faculty-to-Student Ratio – 10% 
  • International Research Network – 10% 
  • Citations per Paper – 10% 
  • Papers per Faculty – 5% 
  • Staff with PhDs – 5% 
  • International Faculty Ratio – 2.5% 
  • International Student Ratio – 2.5% 
  • Inbound Exchange Students – 2.5% 
  • Outbound Exchange Students – 2.5% 

For more information, visit: https://www.chula.ac.th/en/news/432915/ 

Media Contact:  
Chula Communication Center
Email: Pataraporn.r@chula.ac.th 

Thai Airways Reports Breach Involving Over 60,000 Passenger Records

Thai Airways is investigating a breach potentially exposing over 60,000 passenger records, with passport details among additional information possibly accessed. (Photo: Thai Airways)

Thai Airways is investigating unauthorized access to passenger booking information held by its service provider Amadeus, with around 60,529 records potentially affected, the airline said on 9 November.

The airline will notify affected passengers individually after checking the information supplied by Amadeus. It has reported the incident to the relevant authorities, while its review of the affected records continues.

The information potentially accessed includes passenger names and booking references, alongside travel dates, routes, and cabin classes.

The airline also identified around 376 additional records that may contain more extensive personal details, including passport numbers, nationalities, phone numbers, email addresses, and frequent flyer membership numbers. Flight, ticket, and seat numbers may also be involved.

The figures refer to passenger records. Thai Airways’ statement did not establish how many individual travelers those records represent.

The incident concerns booking data stored in Amadeus systems between 10 August 2023 and 23 September. Amadeus provides the airline’s passenger service systems and informed Thai Airways of the unauthorized access.

Thai Airways said credit card information was unaffected and that its own systems and flight operations had not been disrupted.

Amadeus has since revoked the login credentials used to access the information and reset affected passwords, according to the airline. It has also reinforced its monitoring and detection measures to help prevent further unauthorized access.

As of 9 November, Thai Airways said it had found no evidence that the affected information had been disclosed. That finding remains separate from the unauthorized access under investigation.

The airline apologized to passengers for the concern and inconvenience caused and said individual notifications would follow once it had verified the relevant details.

Malaysia Airlines Secures Major Accolades for Service and MICE Offering

Dual recognition across customer service and MICE strengthens the airline’s proposition as it continues to advance its customer experience and commercial offering


HONG KONG SAR – Media OutReach Newswire – 11 November 2026 – Malaysia Airlines has secured major accolades across customer service and the meetings, incentives, conferences and exhibitions (MICE) segment, reinforcing its customer proposition as it continues to advance its transformation under Malaysia Aviation Group’s (MAG) Long-Term Business Plan 3.0 (LTBP3.0).

Malaysia Airlines Secures Major Accolades for Service and MICE Offering
Malaysia Airlines Secures Major Accolades for Service and MICE Offering

At the 2026 Skytrax World Airline Awards, Malaysia Airlines was named Best Airline Staff in Asia, while its cabin crew ranked third in the World’s Best Airline Cabin Crew category, rising five places from eighth in 2025. The airline also climbed six places to 21st in the World’s Top 100 Airlines ranking. Other results included second place in World’s Best Airport Services, a debut at 18th in World’s Best Business Class Airlines, 12th in World’s Best Economy Class Airlines, 11th in World’s Cleanest Airline and 10th among the Top 10 Airlines in Asia.

Captain Nasaruddin A. Bakar, President and Group Chief Executive Officer of MAG, said, “This recognition is a reflection of the collective efforts of our people across the airport, onboard and behind the scenes, who come together every day to deliver Malaysian Hospitality throughout the customer journey. Reaching this milestone after years of consistently climbing the global rankings is a significant achievement for our national carrier and a direct reward for our team’s relentless effort. It is this spirit of warm, thoughtful and consistent service that sets the Malaysia Airlines experience apart.”

Over the past two years, the airline has continued to elevate the customer experience, focusing on cabin comfort, in-flight dining and cabin crew service delivery. Initiatives have included expanded hospitality training and capability-building for frontline teams, strengthened service standards and more than 20 enhancements across key customer touchpoints. These range from refreshed cabin crew grooming standards and personalised Pilot Farewell Greetings to enhanced Business Class and Business Suite amenities, alongside family-focused initiatives such as children’s sticker giveaways and dedicated World Children’s Day celebrations onboard. The airline has also continued to evolve its in-flight dining experience through monthly menu rotations and more than 30 new menu offerings introduced over the past year, including Vegetarian Satay and Cendol Ice Cream.

Meanwhile, Malaysia Airlines was named World’s Best MICE Airline and Asia’s Best MICE Airline at the 2026 World MICE Awards, marking its first wins in both categories. The accolades recognise the airline’s role in serving the international MICE segment and reinforce its proposition to travel trade partners across the business events and corporate travel sectors.

Bryan Foong, Chief Executive Officer of Airline Business from MAG, said, “This recognition is an important milestone for Malaysia Airlines, and one we look to build on as we continue to enhance our offering and strengthen our relationships with travel trade partners. Our progress depends on the collective efforts of teams across the Group, working together to deliver a reliable and seamless travel experience grounded in authentic Malaysian Hospitality. As we move forward, we remain focused on building partner confidence, deepening collaboration and delivering sustainable growth for the airline.”

Beyond these achievements, Malaysia Airlines continues to develop its onboard proposition and expand its network to provide customers with greater choice and connectivity. Fleet renewal remains a key priority, with 29 new aircraft received to date and plans to build a fleet of 117 aircraft by 2035 to support future network growth.

The airline’s focus on operational performance also remains central to delivering a consistent customer experience, with year-to-date on-time performance (OTP) averaging 91.70% and reaching a high of 94.16% in September 2026.

These developments support MAG’s LTBP3.0, which sets out the ambition for Malaysia Airlines to rank among the Top 10 Global Airlines by 2030. Through continued investment in its products, services, fleet and network, the Group aims to build a more competitive airline and deliver sustainable long-term growth.

Malaysia Airlines invites travellers in Hong Kong to discover its award-winning Malaysian Hospitalityto Kuala Lumpur, the Maldives, Singapore, Bali, Brisbane and beyond. Book via the Malaysia Airlines website (https://www.malaysiaairlines.com/hk/en/home.html) or mobile app and start planning your next getaway.

Hashtag: #MalaysiaAirlines

The issuer is solely responsible for the content of this announcement.

About Malaysia Airlines

Malaysia Airlines is the national carrier of Malaysia, offering premium and full-service travel options to, from, and within the country. As the gateway to Asia and beyond, the airline carries up to 40,000 guests daily on memorable journeys inspired by Malaysia’s diverse heritage. Malaysia Airlines embodies the nation’s rich traditions, cultures, and cuisines, delivering an unparalleled experience through its signature Malaysian Hospitality across every customer touchpoint.

Since September 2015, the airline has been owned and operated by Malaysia Airlines Berhad. It is part of the Malaysia Aviation Group (MAG) – a global aviation organisation comprising a range of aviation and lifestyle travel solution portfolios aimed at serving global air travel needs.

As a member of the oneworld® alliance, Malaysia Airlines offers enhanced connectivity to more than 900 destinations in 170 territories worldwide. For more information, visit www.malaysiaairlines.com or download the Malaysia Airlines app for the latest promotions at your fingertips.

Issued by Group Communications, Malaysia Aviation Group.

HGC Appoints Dr Frédéric Schepens as Chief Executive Officer


HONG KONG SAR – Media OutReach Newswire – 11 November 2026 – HGC Global Communications(“HGC” or the “Group”), a Hong Kong-based digital infrastructure, connectivity and ICT solutions provider with international reach, today announced the appointment of Dr Frédéric Schepens (Fred) as Chief Executive Officer, effective 1 November 2026. Fred succeeds Andrew Kwok, who has decided that the time is right to begin the next chapter of his career outside the Group and will support a smooth handover to ensure continuity.

Dr Frédéric Schepens appointed as Chief Executive Officer of HGC
Dr Frédéric Schepens appointed as Chief Executive Officer of HGC

Fred will lead HGC’s next phase of growth, overseeing the Group’s strategy and operations across its enterprise, consumer, carrier and international businesses. With Hong Kong as its home market, HGC will continue to serve local households and businesses while strengthening the city’s role as an international digital hub connecting Asia and the world.

Fred is a seasoned telecoms leader with 30 years of international experience across Europe, Asia, the Middle East and Africa. He founded and led Bayobab, MTN Group’s open-access digital infrastructure business. He previously held senior carrier leadership roles at Vodafone and BICS.

Darrin Webb, Executive Vice Chairman of HGC, said, “Fred has built and grown digital infrastructure businesses and knows how to work with customers and partners across markets. That experience is a strong fit for HGC as we expand our businesses and deepen our partnerships in Hong Kong, across Asia and beyond. We are delighted to welcome Fred as CEO. I also want to thank Andrew for his leadership and for the trust he and the team have earned over the years.”

Andrew Kwok said, “Leading HGC has been a true privilege. Through years of rapid industry change and challenging market conditions, our talented and dedicated team has shown remarkable resilience, and HGC has evolved and grown stronger as a result. I am deeply grateful to our colleagues, customers and partners for their trust and support. I look forward to continuing to contribute to the industry in a new capacity. Fred brings exceptional international experience across networks, carrier services and digital infrastructure, and I am confident he will lead HGC to even greater success.”

Dr Frédéric Schepens, Chief Executive Officer of HGC, said, “I am proud to join HGC and build on the expertise of our people and the trust of our customers. My focus is clear: to strengthen our core businesses and bring our connectivity, digital infrastructure and ICT capabilities closer together to help customers operate securely and adopt AI with confidence. We will be ambitious in our thinking and disciplined in our execution. I look forward to working closely with our people, customers and partners to turn these priorities into practical results.”

Hashtag: #HGC


The issuer is solely responsible for the content of this announcement.

About HGC Global Communications Limited

HGC Global Communications Limited (HGC) is a Hong Kong and international telecommunications operator and ICT solutions provider. The company owns extensive network infrastructure in Hong Kong and overseas, with 19 global offices and a staff presence in 33 cities worldwide. HGC provides telecommunications infrastructure services to other operators, as well as connectivity, ICT solutions and broadband services to enterprises, SMEs and households in local and international markets. HGC owns and operates an extensive fibre-optic network and five cross-border telecommunications routes integrated with tier-one operators in Chinese Mainland, and connects with hundreds of international telecommunications operators. The company continues to invest in its infrastructure, technologies and services. In 2019, HGC Group acquired Macroview Telecom Limited (Macroview), a digital technology solutions and managed services provider, strengthening the Group’s ICT and digital services capabilities. HGC is a portfolio company of I Squared Capital, an independent global infrastructure investment manager focused on energy, utilities, transport, social infrastructure, digital infrastructure and environmental infrastructure in North America, Europe, Latin America and Asia.

To learn more, please visit HGC’s website at:
LinkedIn: